V I Reus1. Show Affiliations » 1. Langley Porter Psychiatric Institute, University of California, San Francisco 94143-0984, USA.
Abstract
Entities: Chemical
Mesh: See more » Antipsychotic Agents/adverse effectsAntipsychotic Agents/pharmacologyAntipsychotic Agents/therapeutic useBenzodiazepinesClinical Trials as TopicHumansOlanzapinePirenzepine/adverse effectsPirenzepine/analogs & derivativesPirenzepine/pharmacologyPirenzepine/therapeutic usePsychotic Disorders/drug therapyReceptors, Dopamine D2/drug effectsReceptors, Serotonin/drug effectsSchizophrenia/drug therapy
Substances: See more » Antipsychotic AgentsReceptors, Dopamine D2Receptors, SerotoninBenzodiazepinesPirenzepineOlanzapine
Year: 1997 PMID: 9142055 DOI: 10.1016/S0140-6736(97)22018-0
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321